AKT1 and Alzheimer disease: Taken together, these data suggested that loss of Ctsh mediated by RAPTOR increase and AKT1 activity loss in patients with AD leads to mild epidermal barrier disruption and that the epidermis subsequently becomes more proinflammatory.